Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Brodtmann

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Biorxiv : the Preprint Server for Biology|April 27, 2026
CALM-VLM: CALIBRATION AND SELECTIVE PREDICTION IN VISION-LANGUAGE MODELS FOR RELIABLE BRAIN MRI CLASSIFICATIONNikhil J Dhinagar, Chirag Jagad, Pavithra Senthilkumar, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort StudyNabil Seery, Robb Wesselingh, Paul Beech, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort StudyNabil Seery, Robb Wesselingh, Paul Beech, et al.
JAMA Network Open|December 9, 2025
Consensus-Harmonized Neuropsychological Assessment for Vascular Cognitive Impairment and DementiaAdam C Bentvelzen, Nicole A Kochan, Danit G Saks, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Severe motor impairment is associated with lower contralesional brain age in chronic strokeGilsoon Park, Mahir H Khan, Justin W Andrushko, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
JAMA Neurology|November 29, 2024
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASILGido Gravesteijn, Julie W Rutten, Minne N Cerfontaine, et al.
The Lancet. Digital Health|January 23, 2026
Associations between contralesional neuroplasticity and motor impairment through deep learning-derived MRI regional brain age in chronic stroke (ENIGMA): a multicohort, retrospective, observational studyGilsoon Park, Mahir H Khan, Justin W Andrushko, et al.
The Lancet. Neurology|May 26, 2023
Neuroimaging standards for research into small vessel disease-advances since 2013Marco Duering, Geert Jan Biessels, Amy Brodtmann, et al.
JAMA Neurology|September 16, 2025
Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria, Perminder S Sachdev, Adam C Bentvelzen, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|April 27, 2026
CALM-VLM: CALIBRATION AND SELECTIVE PREDICTION IN VISION-LANGUAGE MODELS FOR RELIABLE BRAIN MRI CLASSIFICATIONNikhil J Dhinagar, Chirag Jagad, Pavithra Senthilkumar, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort StudyNabil Seery, Robb Wesselingh, Paul Beech, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort StudyNabil Seery, Robb Wesselingh, Paul Beech, et al.
JAMA Network Open|December 9, 2025
Consensus-Harmonized Neuropsychological Assessment for Vascular Cognitive Impairment and DementiaAdam C Bentvelzen, Nicole A Kochan, Danit G Saks, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Severe motor impairment is associated with lower contralesional brain age in chronic strokeGilsoon Park, Mahir H Khan, Justin W Andrushko, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
JAMA Neurology|November 29, 2024
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASILGido Gravesteijn, Julie W Rutten, Minne N Cerfontaine, et al.
The Lancet. Digital Health|January 23, 2026
Associations between contralesional neuroplasticity and motor impairment through deep learning-derived MRI regional brain age in chronic stroke (ENIGMA): a multicohort, retrospective, observational studyGilsoon Park, Mahir H Khan, Justin W Andrushko, et al.
The Lancet. Neurology|May 26, 2023
Neuroimaging standards for research into small vessel disease-advances since 2013Marco Duering, Geert Jan Biessels, Amy Brodtmann, et al.
JAMA Neurology|September 16, 2025
Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria, Perminder S Sachdev, Adam C Bentvelzen, et al.
Pageof 20